Joao Manuel Santos publishes his second article in Molecular Therapy (05 Sep 2018)

 Joao Manuel Santos published his second article as the first author named “Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy” in […]



Cancer Bio-Summer School in Helsinki outreach (April – May 2018)

 Joao Manuel Santos and Victor Cervera-Carrascon took part in organizing the 11th Cancer Bio-Summer School in Helsinki. During the course, Master students, PhD students and Postdocs covered the hallmarks of […]



VIRION at the International Oncolytic Virus Conference in Oxford (09-12 Apr 2018)

VIRION team participated in the International Oncolytic Virus Conference in Oxford. Joao Manuel Santos and Tereza Brachtlova presented their findings in the poster session. Four days of inspiring talks, international […]



Victor Cervera-Carrascon publishes his first article in Oncoimmunology. (09 Apr 2018)

Victor Cervera-Carrascon, published his first article “TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade” in Oncoimmunology. Joao Manuel Santos is one of the co-authors. Article can […]



Joao Manuel Santos and Victor Cervera-Carrascon at the Open Doors Day, University of Helsinki (22 Mar 2018)

Joao Manuel Santos and Victor Cervera-Carrascon participated in the “Meilahti day” the Open doors day of the Faculty of Medicine (University of Helsinki). Different groups of 25 students in total […]



Spring Symposium of Netherlands Society of Gene and Cell Therapy (NVGCT) (15-16 Mar 2018)

Yearly spring symposium of Netherlands Society of Gene and Cell Therapy (NVGCT) took place in Lunteren. Tereza Brachtlova presented her results on functional expression of RNA interfering molecules from the […]



Virion ESRs biannual meeting (08-09 Mar 2018)

VIRION-ESRs and their PIs reunite once again. The biannual meeting took place in Helsinki this time, organized by Ioanna Milenova and Joao Manuel Santos. During the days everyone shared their […]



Ioanna Milenova and Marta Lopez-Gonzalez start secondments at TILT Biotherapeutics, Helsinki (Late Feb 2018)

Ioanna Milenova and Marta Lopez-Gonzalez have started their secondments at TILT Biotherapeutics in Helsinki. They will be performing in vivo studies using an established mouse melanoma model.